No Data
No Data
Q4 2023 Agile Therapeutics Inc Earnings Call
Earnings Call Summary | Agile Therapeutics(AGRX.US) Q4 2023 Earnings Conference
The following is a summary of the Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript:Financial Performance:Agile Therapeutics reported a full year net revenue of $19.6 million in 2023, a
Agile Therapeutics Q4 Adj $(1.46) Misses $(0.92) Estimate, Sales $3.62M Miss $4.07M Estimate
Agile Therapeutics (NASDAQ:AGRX) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(0.92) by 58.7 percent. This is a 83.78 percent increase over losses of
Agile Therapeutics: Q4 Earnings Insights
Agile Therapeutics (OTC:AGRX) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM.Here's what investors need to know about the announcement.EarningsAgile Therapeutics missed estim
Press Release: Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand a
Agile Therapeutics 4Q Loss/Shr $1.51 >AGRX
Agile Therapeutics 4Q Loss/Shr $1.51 >AGRX
No Data